These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7944315)

  • 1. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC.
    Peghini PA; Zahner R; Kuster H; Schott H; Schwendener RA
    Antivir Chem Chemother; 1998 Mar; 9(2):117-26. PubMed ID: 9875383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo.
    Ruprecht RM; Bernard LD; Bronson R; Gama Sosa MA; Mullaney S
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):48-55. PubMed ID: 1984055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.
    Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D
    Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
    van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H
    Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia virus.
    Lin TS; Shen ZY; August EM; Brankovan V; Yang H; Ghazzouli I; Prusoff WH
    J Med Chem; 1989 Aug; 32(8):1891-5. PubMed ID: 2754712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
    Dianzani F; Antonelli G; Turriziani O; Dong G; Capobianchi MR; Riva E
    Antiviral Res; 1992 May; 18(1):39-52. PubMed ID: 1384427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.
    Smith MS; Brian EL; De Clercq E; Pagano JS
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1482-6. PubMed ID: 2479334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3'-azido-3'-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5'-triphosphates.
    Kitade Y; Suzuki A; Hirota K; Maki Y; Nakane H; Ono K; Baba M; Shigeta S
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):920-4. PubMed ID: 1381996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.
    Hostetler KY; Richman DD; Sridhar CN; Felgner PL; Felgner J; Ricci J; Gardner MF; Selleseth DW; Ellis MN
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2792-7. PubMed ID: 7695264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-human immunodeficiency virus.
    D'Cruz OJ; Venkatachalam TK; Zhu Z; Shih MJ; Uckun FM
    Biol Reprod; 1998 Sep; 59(3):503-15. PubMed ID: 9716547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA; Ripley D; Hsia K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3'-azido-3'-deoxythymidine metabolites on simian virus 40 origin-dependent replication and heteroduplex repair in HeLa cell extracts.
    Bebenek K; Thomas DC; Roberts JD; Eckstein F; Kunkel TA
    Mol Pharmacol; 1993 Jan; 43(1):57-63. PubMed ID: 8380884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
    Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.